Prism Peptides
Cagrilintide 5mg
Cagrilintide 5mg
Couldn't load pickup availability
🔴 IMPORTANT: Read Before Use
Cagrilintide (Cagri) is a long-acting amylin-based peptide designed to support appetite control, satiety, and weight management. It works by targeting amylin and calcitonin receptors, helping slow gastric emptying, reduce hunger, and improve glucose regulation.
When combined with GLP-1 peptides, Cagrilintide delivers a synergistic effect, enhancing fat loss and appetite suppression beyond what either compound achieves alone.
✨ Key Benefits
🍽️ Reduces appetite and increases fullness
🔥 Enhances weight loss when stacked with GLP-1 peptides
🩸 Supports glucose control and metabolic health
🫀 May improve circulation and blood pressure
🦴 Supports bone health and vasodilation
📊 Expected Results
- 6–10% body weight loss in 26 weeks (Cagrilintide alone)
- 23–24% body weight loss at 68 weeks (with GLP-1 combination)
- Up to 8% greater weight loss vs. GLP-1 alone
💉 Dosing Overview
- Strength: 5mg vial
- Mix: 2 mL bacteriostatic water
- Administration: Subcutaneous
- Cycle: Up to 16 weeks, followed by a 4–6 week break
📌 Always inject on the same day weekly and stay well hydrated.
🔗 Popular Stack Options
✨ GLP-1 peptides – Enhanced appetite suppression
⚡ Energy & fat metabolism supports
🔥 Lipolysis-focused fat loss compounds
🧬 Why Choose Cagrilintide?
✔ Long-acting appetite control
✔ Powerful synergy with GLP-1 peptides
✔ Designed for sustainable, progressive fat loss
✔ Ideal for structured weight management protocols
🔥 Why Stack Tirzepatide + Cagrilintide?
- Tirzepatide (GLP-1/GIP) → controls appetite, blood sugar, and insulin sensitivity
- Cagrilintide (Amylin agonist) → increases satiety, slows gastric emptying
- ✅ Together = stronger appetite suppression, better portion control, and more sustainable fat loss
- ✅ Helps reduce GLP-1 nausea when dosed correctly
🗓️ Suggested Weekly Stack Schedule (Beginner → Intermediate)
📅 Weekly Injection Split (Recommended)
💉 2 injections per week on separate days
| Day | Compound | Why |
|---|---|---|
| Day 1 (e.g. Monday) | Tirzepatide | Primary metabolic & appetite control |
| Day 4 (e.g. Thursday) | Cagrilintide | Extends satiety & smooths hunger between doses |
👉 Splitting days helps reduce GI side effects and improves tolerance.
💉 Dosing Schedule (Conservative & Safe)
Tirzepatide + Cagrilintide Stack
Inject once weekly each (on different days).
🔹 Tirzepatide (Weekly)
Week 1–4: 5 units (2.5 mg)
Week 5–8: 10 units (5 mg)
Week 9–12: 15 units (7.5 mg)
Week 13+: 20 units (10 mg) (only if well tolerated)
🔹 Cagrilintide (Weekly)
Week 1: 4 units (200 mcg)
Weeks 2–3: 8 units (400 mcg)
Weeks 4–5: 12 units (600 mcg)
Weeks 6–7: 16 units (800 mcg)
Weeks 8–10: 20 units (1 mg)
Weeks 11–16: 24 units (1.2 mg)
⚠️ Do not exceed 16 weeks of continuous Cagrilintide use.
⏸️ Washout Recommendation
- Cagrilintide: 4–6 weeks OFF after 16 weeks
- Tirzepatide: May continue solo if tolerated
👉 This reduces the risk of anti-Cagri antibody formation.
💧 Support Tips (Very Important)
✅ Hydrate well (electrolytes help)
✅ Eat slowly, prioritize protein
✅ Avoid large or greasy meals on injection days
✅ If nausea occurs → reduce dose, don’t push through
⚠️ Common Side Effects (Usually Dose-Related)
- Nausea or fullness
- Fatigue
- Constipation or diarrhea
- Injection site redness
- Heartburn
- Gallstones (rare)
💡 These usually improve with slower titration and split dosing.
⭐ Pro Tip (Most Users Miss This)
If appetite is completely gone, do NOT increase dose.
More is not better—consistency beats intensity.
Share
